交易 Filana Therapeutics Inc - FLNA 差价合约

交易条件

• 类型: 差价合约
• 点差: 0.05
• 长仓隔夜仓息调整: -0.02151%
• 短仓隔夜仓息调整: -0.00071%
• 隔夜调整仓息时间: 21:00 (UTC)
• 货币: USD
• 最低成交量: 10
• 保证金: 5.00%
• 证券交易所: United States of America
• 交易佣金: 0%
• 保证止损溢价: 1%

主要统计数据

• 前收盘价: 1.66
• 开仓: 1.66
• 1 年变化: 3.75%
• 日区间: 1.59 - 1.66

交易 Filana Therapeutics Inc - FLNA 差价合约

Cassava Sciences Inc. (NASDAQ: SAVA) is a clinical-stage biotech company focused on developing Simufilam, an oral drug candidate for Alzheimer’s disease. Its platform is based on stabilizing a scaffolding protein (filamin A) thought to disrupt Alzheimer’s pathology. While the company faces scientific scrutiny and clinical trial volatility, it continues to advance large-scale Phase 3 studies. Cassava offers speculative exposure to high-stakes neurodegeneration treatment development with transformative, albeit controversial, upside potential.